Filter
254
Text search:
inactivated
vaccines
Featured
Recommendations
24
New Publications
72
Language
Document type
No document type
109
Guidelines
71
Studies & Reports
29
Fact sheets
17
Manuals
15
Strategic & Response Plan
6
Situation Updates
5
Training Material
1
Resource Platforms
1
Countries / Regions
Global
12
Pakistan
8
India
7
Sierra Leone
6
Nigeria
6
Philippines
6
South Africa
6
Afghanistan
5
Tanzania
5
Syria
4
Kenya
4
Ukraine
4
Chile
4
Latin America and the Carribbean
4
Ethiopia
3
Uganda
3
Nepal
3
Germany
3
Africa
3
Liberia
2
Congo, Democratic Republic of
2
Namibia
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Venezuela
2
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Zambia
1
Turkey
1
Egypt
1
China
1
Rwanda
1
Bangladesh
1
Malawi
1
Papua New Guinea
1
Argentina
1
Peru
1
Brazil
1
Colombia
1
Ecuador
1
Botswana
1
Bolivia
1
Libya
1
Yemen
1
West and Central Africa
1
Paraguay
1
Solomon Islands
1
Bhutan
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
74
Clinical Guidelines
38
Women & Child Health
12
Public Health
5
Pharmacy & Technologies
4
Key Resources
3
Capacity Building
2
Toolboxes
COVID-19
67
Polio
28
Ebola & Marburg
14
Rapid Response
12
NTDs
10
TB
9
Pharmacy
9
HIV
7
Cholera
6
Conflict
6
Refugee
5
2.0 Rapid Response
5
Zika
4
Planetary Health
3
Natural Hazards
2
Mental Health
2
AMR
2
Health Financing Toolbox
2
Specific Hazards
1
Global Health Education
1
NCDs
1
Malaria
1
24 September 2021. The vaccine has been authorized by the Chinese National Regulatory Authority (NRA) – the National Medicinal Product Administration (NMPA) – as well as other regulatory authorities. Because WHO has granted Emergency Use Listing (EUL) for the Sinovac COVID-19 vaccine (Vero Cell
...
The purpose of this field guide is to provide comprehensive information on planning and implementing high-quality3 SIAs for injectable vaccines and highlight the opportunities to strengthen RI and surveillance. The guide uses measles–rubella SIAs
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID
...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covi
...
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recomm
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, prepared
...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an
...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) h
...
Update 2021; Immunization, Vaccines and Biologicals
This guide provides a comprehensive overview of essential information related to immunization, including technical information about vaccines, a review of immunization program management best practices, guidance on the delivery of immunization servi
...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendation
...
In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle the pandemic. In June 2020, the Gavi COVAX Advance Market Commitment (AMC) was launched to financ
...
The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations.
It covers the following items:
Global Reports
Immunization Agenda 2030 and Regional reports
Monkeypox
RSV
COVID-19
...
28 Dec 2020. The main objective of these guidelines is to provide tools for staff working in the field of immunization to support effective communication between health personnel and the general population, with the aim of strengthening, maintaining or recovering trust in
...
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan
...
3 February 2021
Vaccine- and vaccination-related crises require a communication response that is different from the communication strategies used to promote the benefits and importance of vaccines in general. This document presents the technical gu
...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality.
...
